Elsevier

Brain Research

Volume 559, Issue 2, 20 September 1991, Pages 352-356
Brain Research

Facilitatory role of calcitonin gene-related peptide (CGRP) on excitation induced by substance P (SP) and noxious stimuli in rat spinal dorsal horn neurons. An iontophoretic study in vivo

https://doi.org/10.1016/0006-8993(91)90024-PGet rights and content

Abstract

The effects of iontophoretically applied calcitonin gene-related peptide (CGRP) and/or substance P (SP) onto physiologically identified neurons in the rat lumbar dorsal horn were studied. The consistent excitatory effects of SP found on the spontaneous and the noxious evoked activity were significantly potentiated by CGRP application. This peptide facilitated the noxious evoked activity and did not affect the spontaneous activity of the neurons. The response to non-noxious stimuli were unaffected in all cases.

Reference (30)

Cited by (100)

  • Migraine headache pathophysiology

    2023, Handbook of Clinical Neurology
  • Expression pattern of type 3 adenylyl cyclase in rodent dorsal root ganglion and its primary afferent terminals

    2019, Neuroscience Letters
    Citation Excerpt :

    CGRP release from its storage vesicles can be stimulated by neonatal capsaicin [23]. CGRP could potentiate substance P function in the spinal dorsal horn [24,25] as well as enhance release of substance P [26] and excitatory amino acids [27] from primary afferents. Furthermore, CGRP is released in the spinal cord following noxious mechanical, thermal or electrical stimulation [28].

  • A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain

    2015, Experimental Neurology
    Citation Excerpt :

    It has recently been implicated in the pathophysiology of TMDs in chronic masticatory muscle pain within the primary afferent neurons (Dessem and Lovering, 2011; Kehl et al., 2000; Ohlen et al., 1987). Previously it was thought that CGRP release from primary afferents modulates pain transmission only through interactions with substance P and excitatory amino acids (Biella et al., 1991; Oku et al., 1987; Smullin et al., 1990), but it is now also thought to cause hyperalgesia and central sensitization independent of these mechanisms (Lian et al., 2010; Sun et al., 2003, 2004). In the trigeminovascular system CGRP release is involved in sensitizing the primary afferent neurons causing peripheral and central sensitization in craniofacial inflammatory, neuropathic and migraine pain (Cady et al., 2011; De Felice et al., 2010).

  • Sensory nerve fibers containing calcitonin gene-related peptide in gastrocnemius, latissimus dorsi and erector spinae muscles and thoracolumbar fascia in mice

    2015, Neuroscience
    Citation Excerpt :

    Likewise, intrathecal administration of both peptides facilitates the pain withdrawal reflex to an exaggerated and more prolonged extent than administration of either peptide alone (Woolf and Wiesenfeld-Hallin, 1986). CGRP enhances SP-mediated transmission in three ways: CGRP can potentiate release of SP, presumably by a presynaptic action (Oku et al., 1987); it can enhance excitability of neurons receiving nociceptive inputs, at least in part by potentiating the actions of SP itself (Biella et al., 1991; Seybold et al., 2003; Sun et al., 2004; Bird et al., 2006); and it can inhibit the degradation of SP, thereby prolonging its action (Le Greves et al., 1985). Plastic changes in peptidergic sensory nerves that supply muscle may contribute to chronic muscle pain.

View all citing articles on Scopus
View full text